Cargando…
Synthesis and Anti-Angiogenic Activity of Novel c(RGDyK) Peptide-Based JH-VII-139-1 Conjugates
Peptide–drug conjugates are delivery systems for selective delivery of cytotoxic agents to target cancer cells. In this work, the optimized synthesis of JH-VII-139-1 and its c(RGDyK) peptide conjugates is presented. The low nanomolar SRPK1 inhibitor, JH-VII-139-1, which is an analogue of Alectinib,...
Autores principales: | Leonidis, George, Koukiali, Anastasia, Sigala, Ioanna, Tsimaratou, Katerina, Beis, Dimitris, Giannakouros, Thomas, Nikolakaki, Eleni, Sarli, Vasiliki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962512/ https://www.ncbi.nlm.nih.gov/pubmed/36839704 http://dx.doi.org/10.3390/pharmaceutics15020381 |
Ejemplares similares
-
Synthesis and Biological Evaluation of a c(RGDyK)
Peptide Conjugate of SRPIN803
por: Leonidis, George, et al.
Publicado: (2021) -
Nuclear Translocation of SRPKs Is Associated with 5-FU and Cisplatin Sensitivity in HeLa and T24 Cells
por: Sigala, Ioanna, et al.
Publicado: (2021) -
First in-human radiation dosimetry of (68)Ga-NODAGA-RGDyK
por: Gnesin, Silvano, et al.
Publicado: (2017) -
Good Cop, Bad Cop: The Different Roles of SRPKs
por: Nikolakaki, Eleni, et al.
Publicado: (2022) -
[(68)Ga]Ga-DFO-c(RGDyK): Synthesis and Evaluation of Its Potential for Tumor Imaging in Mice
por: Krajcovicova, Sona, et al.
Publicado: (2021)